Real-time enrollment status for this colorectal cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:39 AM UTC
| NCT Number | NCT06885034 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Cancer |
| Phase | PHASE1 |
| Target Enrollment | 451 participants |
| Active Locations | 12 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | August 3, 2026 (4 weeks ago) |
As of August 31, 2026: Clinical trial NCT06885034 is currently recruiting participants. This phase1 study for colorectal cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06885034 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06885034 was last updated 4 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.